Conflicted psychiatrist leaves Emory

The Emory University psychiatry researcher who failed to report hundreds of thousands of dollars in pharmaceutical company payouts while receiving millions of dollars in funding from the National Institutes of Health to study the company's anti-depressant drugs is leaving the university, according to the linkurl:__Atlanta Journal-Constitution__.;http://www.ajc.com/health/controversial-emory-researcher-leaving-179261.html?cxtype=rss_news_128746 linkurl:Charles Nemeroff,;http://www.psychiatry.emo

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
The Emory University psychiatry researcher who failed to report hundreds of thousands of dollars in pharmaceutical company payouts while receiving millions of dollars in funding from the National Institutes of Health to study the company's anti-depressant drugs is leaving the university, according to the linkurl:__Atlanta Journal-Constitution__.;http://www.ajc.com/health/controversial-emory-researcher-leaving-179261.html?cxtype=rss_news_128746 linkurl:Charles Nemeroff,;http://www.psychiatry.emory.edu/NeuropsychopharmacologyLaboratory/Charles%20Nemeroff.htm# a renowned depression researcher, failed to disclose to Emory approximately $800,000 in payments he received from drug maker GlaxoSmithKline (GSK) while he was the principal investigator (PI) on a multi-million dollar grant from the NIH to study five GSK antidepressants. Amid an investigation conducted by Emory, Nemeroff stepped down from his position as chairman of the psychiatry department last October. Later that month, the psychiatrist stepped down as PI from the $9.3 million NIH grant as the Senate probed his failure to disclose income from GSK, and the NIH froze funding on the five-year grant. Emory officials told the __Atlanta Journal-Constitution__ that Nemeroff had not officially submitted his resignation as of last Friday (30th October), but that they were contacted by the institution that is hiring Nemeroff. They did not disclose what institution that was, but said that the university would issue an official announcement regarding Nemeroff's departure sometime today (2nd November). Ed Silverman over at the __Pharmalot__ blog linkurl:reported;http://www.pharmalot.com/2009/10/amid-inquiries-nemeroff-looks-beyond-emory/ last week that the University of Miami's Miller School of Medicine would be Nemeroff's new home, citing "sources familiar with the school."
**__Related stories:__***linkurl:NIH to act on conflicts within 1 year;http://www.the-scientist.com/blog/display/55264/
[5th December 2008]*linkurl:NIH $ frozen amid conflict probe;http://www.the-scientist.com/blog/display/55088/
[14th October 2008]*linkurl:Emory psychiatrist steps down;http://www.the-scientist.com/blog/display/55072/
[6th October 2008]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies